Liang Ouyang - Concepedia

Author

Liang Ouyang

Also Known As

L Ouyang, L. OU-YANG, L. Ouyang, L., Ouyang, L.J. Ouyang, LIANG OUYANG, Lanxin Ouyang, Li-xin Ouyang, Liang OUYANG, Liang OUyang

246

Publications

10.2K

Citations

H-Index

122

Concepts

All Affiliations

Sichuan University State Key Laboratory of Biotherapy West China Hospital of Sichuan University Shenyang Pharmaceutical University Chengdu University of Traditional Chinese Medicine

About

Liang Ouyang is an author at Sichuan University specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	39	1.7K
2	Natural Sciences	18	19	774
3	Engineering	13	13	602
4	Biochemistry	13	13	477
5	Biomedical Engineering	4	4	163

Liang Ouyang

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Effects of biochar amendment on soil aggregates and hydraulic properties Liang Ouyang, Fangli Wang, Jia Tang, Journal of soil science and plant nutrition	2013	242
Aggregable Nanoparticles-Enabled Chemotherapy and Autophagy Inhibition Combined with Anti-PD-L1 Antibody for Improved Glioma Treatment Shaobo Ruan, Rou Xie, Lin Qin, Nano Letters NanoparticlesEngineeringImmunologyCell DeathHigh-grade Gliomas	2019	194
Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo Lan Zhang, Leilei Fu, Shouyue Zhang, Chemical Science	2017	162
Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer Yang Shu, Weihan Zhang, Qianqian Hou, Nature Communications	2018	140
Recent advances in the design and discovery of synthetic tyrosinase inhibitors Jin Li, Lu Feng, Li Liu, European Journal of Medicinal Chemistry Medicinal ChemistryBiochemistrySynthetic Tyrosinase InhibitorsNatural SciencesMedicine	2021	134
Recent Progress on Tubulin Inhibitors with Dual Targeting Capabilities for Cancer Therapy Shuai Wen, Guan Wang, Yiwen Zhang, Journal of Medicinal Chemistry	2021	131
Tumor Microenvironment‐Responsive Dual Drug Dimer‐Loaded PEGylated Bilirubin Nanoparticles for Improved Drug Delivery and Enhanced Immune‐Chemotherapy of Breast Cancer Xiaotong Yang, Chuan Hu, Fan Tong, Advanced Functional Materials NanoparticlesImproved Drug DeliveryNanotherapeuticsEngineeringBiomedical Engineering	2019	111
New techniques and strategies in drug discovery Jintong Du, Jing Guo, Dongwei Kang, Chinese Chemical Letters Medicinal ChemistryDrug TargetHit IdentificationNatural SciencesDrug Design	2020	109
Discovery of a Small-Molecule Bromodomain-Containing Protein 4 (BRD4) Inhibitor That Induces AMP-Activated Protein Kinase-Modulated Autophagy-Associated Cell Death in Breast Cancer Liang Ouyang, Lan Zhang, Jie Liu, Journal of Medicinal Chemistry Cancer ResearchMitophagyCell AutophagySignaling PathwayBrd4-ampk Interaction	2017	94
Crystal structure-based discovery of a novel synthesized PARP1 inhibitor (OL-1) with apoptosis-inducing mechanisms in triple-negative breast cancer Leilei Fu, Shuya Wang, Xuan Wang, Scientific Reports	2016	91

Page 1